Profile

Eukaryotic Initiation Factor-4E












Gene Expression Regulation, Neoplastic




Precursor T-Cell Lymphoblastic Leukemia-Lymphoma




Cell Transformation, Neoplastic

Trends
Explore the Research Trends
Research Network
Explore the Expert Network
Publications
-
1.
2012Elisa Oricchio; Hans-Guido Wendel
Mining the cancer genome uncovers therapeutic activity of EphA7 against lymphoma
Cell Cycle. 2012;11(6):1076-1080. -
2.
2011Jonathan H. Schatz; Hans-Guido Wendel
Targeted cancer therapy: What if the driver is just a messenger?
Cell Cycle. 2011;10(22):3830-3833. -
3.
2011Elisa Oricchio; Gouri Nanjangud; Andrew L. Wolfe; Jonathan H. Schatz; Konstantinos J. Mavrakis; Man Jiang; Xiaoping Liu; Joanne Bruno; Adriana Heguy; Adam B. Olshen; et al.
The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma
Cell. 2011;147(3):554-564.
Similar Experts
- Publications
- 195










- 190










- 146










- 489










Journals
-
Publications
-
7
-
3
-
2
-
2
-
1
Grants*
-
1.
-
2.
Hans Wendel
EphA receptor signaling-a new, soluble tumor suppressor pathway in lymphoma
Starr Cancer Consortium
Funding: $ 480,000
-
3.
Hans Wendel
The contribution of protein in translation to tumorigenesis
National Cancer Institute
Funding: $ 1,012,600
*Grants count displayed may not represent all of an Expert's awards. Only awards managed by the Grants & Contracts office are posted.
Institutional Network
-
Internal OrganizationsShared Pub.
-
9









-
6









-
5









-
4









-
2









-
2









-
External OrganizationsShared Pub.
-
5
-
5
-
5
-
5
-
4
-
3

